RxDoctor Payments DataLook up a doctor →

Fred Ghali

Pediatric Dermatology · Grapevine, TXNPI 1639286339

Payments from drug & device makers

$907,776in general payments, 2019–2025

Across 1,560 payments — averaging $581.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$250K
  • Regeneron Healthcare Solutions, Inc.$156K
  • Arcutis Biotherapeutics, Inc.$68K
  • Incyte Corporation$66K
  • Eli Lilly$63K
  • Dermavant Sciences, Inc.$62K
  • plus $242K from 33 others
$6,940in research payments, 2019–2025

Across 5 payments — averaging $1388.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Almirall LLC$4K
  • Eli Lilly$3K
  • LEO Pharma AS$700

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few pediatric dermatology providers in Texasto place this figure against a meaningful peer group, so we don't.

Other pediatric dermatology in Grapevine

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →